ALLK
$5.45
Allakos
($.05)
(.91%)
ALLK
Earnings Whisper ®
N/A
1st Quarter March 2023
Consensus:  ($0.53)
Revenue:  N/A
Monday
Jun 5
4:05 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when ALLK reports earnings?
Beat
Meet
Miss

Where is ALLK's stock price going from here?
Up
Flat
Down
Stock chart of ALLK
Analysts
Summary of analysts' recommendations for ALLK
Score
Grade
Pivots
Resistance
$5.65
$5.57
$5.51

$5.43

Support
$5.37
$5.29
$5.23
Tweet
Growth
Description
Allakos Inc. is a clinical stage bio-technology company. It discovers and develops therapeutic antibodies for the treatment of allergic, inflammatory and proliferative diseases. Allakos Inc. is based in CA, United States.